Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1 to 50 of 2013

TitleReference numberPublishedLast updated
12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mitesTA1045
3C Patch for treating diabetic foot ulcersHTG615
Ab externo canaloplasty for primary open-angle glaucomaHTG448
Ab interno canaloplasty for open-angle glaucomaHTG647
Abaloparatide for treating osteoporosis after menopauseTA991
Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal)TA568
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritisTA373
Abdominal aortic aneurysm: diagnosis and managementNG156
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerTA563
Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrenceTA810
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyTA725
Abiraterone (originator and generics) for treating newly diagnosed high-risk hormone‑sensitive metastatic prostate cancerTA1110
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimenTA259
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA387
Abortion careNG140
Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitisTA814
Acalabrutinib for treating chronic lymphocytic leukaemiaTA689
Acne vulgaris: managementNG198
Acoramidis for treating transthyretin amyloidosis with cardiomyopathyTA1121
Acute coronary syndromesNG185
Acute heart failure: diagnosis and managementCG187
Acute kidney injury: prevention, detection and managementNG148
Acute upper gastrointestinal bleeding in over 16s: managementCG141
Acutely ill adults in hospital: recognising and responding to deteriorationCG50
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (terminated appraisal)TA1076
Adalimumab and dexamethasone for treating non-infectious uveitisTA460
Adalimumab for treating moderate to severe hidradenitis suppurativaTA392
Adalimumab for treating moderate to severe plaque psoriasisTA146
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young peopleTA455
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failedTA715
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failedTA375
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitorTA195
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis BTA96
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan IHTG467
Adrenal insufficiency: identification and managementNG243
Advanced breast cancer: diagnosis and treatmentCG81
Advocacy services for adults with health and social care needsNG227
Afamelanotide for treating erythropoietic protoporphyriaHST27
Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)TA444
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancerTA310
Aflibercept for treating choroidal neovascularisationTA486
Aflibercept for treating diabetic macular oedemaTA346
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusionTA409
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusionTA305
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapyTA307
Aflibercept solution for injection for treating wet age‑related macular degenerationTA294
Age-related macular degenerationNG82
Agomelatine for the treatment of major depressive episodes (terminated appraisal)TA231
Air pollution: outdoor air quality and healthNG70
Alcohol interventions in secondary and further educationNG135

Results per page

  1. 10
  2. 25
  3. 50
  4. All